Ifp Advisors, Inc Vista Gen Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.88 - $1.73 $3,012 - $5,921	3,423 New	3,423 $5,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.73 $3,012 - $5,921	-3,423 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$1.14 - $2.09 $3,902 - $7,154	3,423 New	3,423 $0

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.